Cipla: Board Meeting Scheduled to Approve Q2 Results

Cipla has announced a board meeting on October 30, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025 (Q2). Additionally, the company has declared a trading window closure for insiders from October 1, 2025 to November 1, 2025.

Upcoming Board Meeting

A meeting of the Board of Directors of Cipla is scheduled for October 30, 2025. The primary agenda includes reviewing and approving the unaudited financial results.

Financial Results on the Agenda

The board will consider and approve the standalone and consolidated financial results for the quarter and half-year period ending September 30, 2025. This corresponds to the company’s financial performance for Q2.

Trading Window Closure

In compliance with insider trading regulations, Cipla has announced a trading window closure. The window will be closed from October 1, 2025 to November 1, 2025. This restriction applies to individuals involved in dealing with the company’s securities.

Source: BSE

Previous Article

Rashtriya Chemicals and Fertilizers: Business Responsibility and Sustainability Report Highlights

Next Article

Lupin: Receives Tentative FDA Approval for HIV Treatment

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *